18 July 2017 - Medibank Private’s share price has had a choppy run in the past few months and the volatility shows no signs of ending soon.

The health insurer’s stock was sold down by 3.7% yesterday after Goldman Sachs slapped a fairly robust sell recommendation on the company.

Medibank stock had been trading above the $3 mark just two months ago and closed last night at $2.79.

Read The Australian article